Optometry: Open Access
Open Access

Diabetic retinopathy (DR) is a common microvascular complication of diabetes mellitus and one of the leading causes of vision impairment and blindness worldwide. It arises due to prolonged hyperglycemia, which damages the blood vessels in the retina, the light-sensitive tissue at the back of the eye responsible for vision. With the global prevalence of diabetes steadily increasing, the incidence of diabetic retinopathy is also on the rise, making it a significant public health concern. Early detection and management are crucial because many patients remain asymptomatic until the disease reaches an advanced stage, at which point vision loss may become irreversible [1,2].

Discussion

Diabetic retinopathy progresses through distinct stages, starting with mild non-proliferative retinopathy, where microaneurysms, or small areas of balloon-like swelling in retinal blood vessels, appear. As the condition advances to moderate and severe non-proliferative stages, retinal blood vessels become increasingly blocked, depriving parts of the retina of adequate oxygen and nutrients. The most severe form, proliferative diabetic retinopathy, is characterized by the growth of new, fragile blood vessels on the retinal surface. These vessels are prone to bleeding, which can cause vitreous hemorrhage and retinal detachment, leading to significant vision loss [3,4].

Macular edema, a related condition, occurs when fluid leaks into the macula—the central part of the retina—resulting in blurred vision and loss of central visual acuity. Risk factors for the development and progression of DR include the duration of diabetes, poor glycemic control, hypertension, hyperlipidemia, and kidney disease [5,6].

Diagnosis of diabetic retinopathy relies on a comprehensive eye examination, including visual acuity testing, fundus photography, optical coherence tomography (OCT), and fluorescein angiography to detect subtle retinal changes. Early detection through regular screening is vital, as interventions are more effective before extensive retinal damage occurs [7,8].

Management strategies focus on both systemic control and ocular treatment. Tight regulation of blood glucose, blood pressure, and lipid levels can significantly slow the progression of retinopathy. For advanced cases, ophthalmic treatments such as laser photocoagulation, intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) agents, and vitrectomy surgery may be required to preserve vision. Patient education and adherence to follow-up appointments are equally important to ensure timely intervention [9,10].

Conclusion

Diabetic retinopathy remains a leading cause of preventable blindness, highlighting the importance of early detection, consistent monitoring, and comprehensive management. As diabetes prevalence continues to rise, healthcare systems must prioritize screening programs, patient education, and multidisciplinary care to mitigate vision loss. With advances in retinal imaging and treatment modalities, individuals with diabetic retinopathy can maintain better visual outcomes if the disease is identified and managed promptly. Ultimately, addressing diabetic retinopathy not only improves quality of life but also reduces the socio-economic burden associated with diabetes-related vision impairment.

References

• Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, et al.(2010) Hoekstra RM, International Collaboration on Enteric Disease 'Burden of Illness S. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis 50:882-889.

  Google Scholar, Cross Ref, Indexed at.

• Hohmann EL (2001) Nontyphoidal salmonellosis. Clin Infect Dis 32:263-269.

  Google Scholar, Cross Ref, Indexed at.

• Relhan N, Pathengay A, Albini T, Priya K, Jalali S, et al. (2014) A case of vasculitis, retinitis and macular neurosensory detachment presenting post typhoid fever. J Ophthalmic Inflamm Infect 18:4-23.

  Google Scholar, Cross Ref, Indexed at.

• Sinha MK, Jalali S, Nalamada Semin S (2012) Review of endogenous endophthalmitis caused by Salmonella species including delayed onset Salmonella typhi endophthalmitis. Ophthalmol 27:94-98.

  Google Scholar, Cross Ref, Indexed at.

• Fusco R, Magli A, Guacci P (1986) stellate maculopathy due to Salmonella typhi. Ophthalmologica 192:154-158.

  Google Scholar, Cross Ref, Indexed at.

• Ellis MJ, Tsai CN, Johnson JW, French S, Elhenawy W, et al. (2019) A macrophage-based screen identifies antibacterial compounds selective for intracellular Salmonella Typhimurium. Nat Commun 10:197.

  Google Scholar, Cross Ref, Indexed at.

• Stapels DAC, Hill PWS, Westermann AJ, Fisher RA, Thurston TL, et al. (2018) Salmonella persisters undermine host immune defenses during antibiotic treatment. Science 362:1156-1160.

  Google Scholar, Cross Ref, Indexed at.

• Pirani V, Pelliccioni P, De Turris S, Rosati A, Franceschi A, et al. (2019) The Eye as a Window to Systemic Infectious Diseases: Old Enemies, New Imaging. J Clin Med 8:1392.

  Google Scholar, Cross Ref, Indexed at.

• Fonollosa A, Giralt J, Pelegrin L (2009) Ocular syphilis–back again: understanding recent increases in the incidence of ocular syphilitic disease. Ocul Immunol Inflamm 17:207-212.

  Google Scholar, Cross Ref, Indexed at.

• Albert DM, Raven ML (2016) Ocular Tuberculosis. Microbiol Spectr 0001-2016.

  Google Scholar, Cross Ref, Indexed at.